Conservative Management of CIN2

被引：0
|
作者：
Rachana Dwivedi
Anannya Kar
Louise Melson
Padma Eedarapalli
机构：
[1] University Hospitals Dorset NHS Trust,Consultant Obstetrics & Gynaecology
来源：
Indian Journal of Gynecologic Oncology | 2021年 / 19卷
关键词：
Conservative management; CIN2; P16; Cold coagulation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Cervical cancer is the third most diagnosed and fourth most common cause of cancer death worldwide. There is established screening programme in UK since 1964. CIN2 and CIN3 were clubbed together and classified as HSIL (high grade squamous intraepithelial dysplasia). As a result CIN2 is being treated by LLETZ (large loop of excision of transformation Zone). CIN2 is the entity where there is more interobserver variation in diagnosis, thereby increasing risk of overtreatment. This can have implications to future fertility especially in younger reproductive age group. This review evaluates other alternative options available with minimal adverse effects.
引用
下载
收藏
相关论文
共 50 条
  • [41] Are CIN2 Lesions Overdiagnosed? Selected Immunopanel Can Prevent Unnecessary Cervical Excisions
    Karabakhtsian, R.
    Cibull, M.
    DeSimone, C.
    MODERN PATHOLOGY, 2011, 24 : 250A - 250A
  • [42] Possible causes of low sensitivity of HPV-DNA testing for CIN2/3
    Guyot, A
    Fox, J
    Karim, S
    Kyi, MS
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2004, 83 (02) : 217 - 218
  • [43] Clinical and analytical performance of the BD Onclarity (TM) HPV assay for detection of CIN2
    Ejegod, Ditte Moller
    Junge, Jette
    Franzmann, Maria
    Kirschner, Benny
    Bottari, Fabio
    Sideri, Mario
    Sandri, Maria-Teresa
    Bonde, Jesper
    PAPILLOMAVIRUS RESEARCH, 2016, 2 : 31 - 37
  • [44] Clinical and economic benefit of HPV-load testing in follow-up and management of women postcone biopsy for CIN2–3
    B Almog
    R Gamzu
    J Bornstein
    I Levin
    O Fainaru
    J Niv
    J B Lessing
    A Bar-Am
    British Journal of Cancer, 2003, 89 : 109 - 112
  • [45] POSTPARTUM CONSERVATIVE MANAGEMENT OF CIN3 DIAGNOSED DURING PREGNANCY
    Kurose, Y.
    Nagai, T.
    Sato, S.
    Uotani, T.
    Hanaoka, T.
    Akahori, T.
    Takai, Y.
    Saito, M.
    Baba, K.
    Seki, H.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 579 - 579
  • [46] THE CASE FOR CONSERVATIVE MANAGEMENT OF INCOMPLETE EXCISION OF CIN AFTER LASER CONIZATION
    LOPES, A
    MORGAN, P
    MURDOCH, J
    PIURA, B
    MONAGHAN, JM
    GYNECOLOGIC ONCOLOGY, 1993, 49 (02) : 247 - 249
  • [47] Analysis of the triage value of multigene methylation testing for CIN2 + in hrHPV-positive patients
    Caiyun Lin
    Chenye Zhu
    Meihua Xie
    Hua Yang
    Infectious Agents and Cancer, 20 (1)
  • [48] Human papilloma virus genotypes for risk assessment of cervical intraepithelial neoplasia grade 2 (CIN2)
    Damgaard, Rikke Kamp
    Jenkins, David
    Stoler, Mark H.
    Lycke, Kathrine Dyhr
    de Koning, Maurits
    Quint, Wim
    Gravitt, Patti
    Steiniche, Torben
    Petersen, Lone Kjeld
    Hammer, Anne
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2023, 102 : 84 - 84
  • [49] THE TREATMENT OF CIN - CONSERVATIVE METHODS
    SINGER, A
    WALKER, P
    CLINICS IN OBSTETRICS AND GYNAECOLOGY, 1985, 12 (01): : 121 - 132
  • [50] Co-factors of high-risk human papillomavirus infections display unique profiles in incident CIN1, CIN2 and CIN3
    Syrjanen, K.
    Shabalova, I.
    Naud, P.
    Derchain, S.
    Sarian, L.
    Kozachenko, V.
    Zakharchenko, S.
    Roteli-Martins, C.
    Nerovjna, R.
    Longatto-Filho, A.
    Kljukina, L.
    Tatti, S.
    Branovskaja, M.
    Branca, M.
    Grunjberga, V.
    Erzen, M.
    Juschenko, A.
    Hammes, L. Serpa
    Costa, S.
    Podistov, J.
    Syrjanen, S.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2011, 22 (05) : 263 - 272
12345